The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Proposed Settlement and Plan of Allocation; (II) Settlement Hearing; and (III) Motion for Attorneys' Fees and Litigation Expenses. Because this website is just a summary, you should review the Notice for additional details.

Summary of the Action

This website relates to the proposed Settlement of claims in a securities class action brought by Perrigo investors alleging, among other things, that Perrigo and former Perrigo CEO Joseph C. Papa (together, “Defendants”) violated the federal securities laws by making false and misleading statements and omissions regarding, among other things (a) the performance and integration of Omega Pharma N.V., which Perrigo acquired in early 2015; and (b) Perrigo’s pricing strategy, noncompetitive practices, and the competitive environment for Perrigo’s generic prescription drug unit. 

Lead Plaintiff on behalf of itself and the Class, has settled the Action for $97,000,000 in cash. On September 5, 2024, the Court held a hearing to consider final approval of the Settlement and other matters. The same day, the Court entered a final Judgment approving the Settlement, the Plan of Allocation, and Lead Counsel’s motion for attorney's fees and litigation expenses. 

The members of the Class (or Classes) are:

1. All persons who purchased Perrigo Company plc’s (“Perrigo”) publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive (the “Class Period”), on the New York Stock Exchange or any other trading center within the United States and were damaged thereby;
    
2. All persons who purchased Perrigo’s publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive, on the Tel Aviv Stock Exchange and were damaged thereby; and
    
3. All persons who owned Perrigo common stock as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered their shares in response to the tender offer of Mylan, N.V.).
    

Excluded from these Classes are the Defendants; Former Defendants; any current member of the Board of Directors of Perrigo; any current or former Officers of Perrigo who served during the Class Period or any former members of the Board of Directors of Perrigo who served during the Class Period; the Immediate Family Members of any Defendant, Former Defendant, or any current member of the Board of Directors of Perrigo, or former member of the Board of Directors of Period who served during the Class Period, or any current or former Officer of Perrigo who served during the Class Period; any entity that any Defendant or Former Defendant owns or controls, or owned or controlled during the Class Period; and the legal representatives, heirs, agents, affiliates, successors, or assigns of any such excluded persons and entities.  Also excluded from the Classes are the persons and entities who requested exclusion from the Classes in connection with the mailing of the Class Notice, or were previously excluded by motion and order. For more information on persons excluded by request, please see the Exclusion List found on the Important Documents tab of this website. 

Please read the Notice to fully understand your rights and options. Copies of the Notice and Claim Form can be found on the Notice and File a Claim pages of this website.
 

Detailed information about the Settlement is contained in the Notice and the documents available on the Important Documents page on this website. Additional information can also be obtained by contacting the Claims Administrator by calling toll-free 1-833-674-0175 or emailing Info@PerrigoSecuritiesLitigation.com or mailing a letter to:

How do I obtain more information?

Perrigo Securities Litigation 
c/o JND Legal Administration
PO Box 91374
Seattle, WA 98111

Inquiries should NOT be directed to the Court or the Clerk of the Court.